Financing - October 4, 2021
Nanoform receives funding from the Bill & Melinda Gates Foundation
Nanoform has announced that Proof of Concept studies will be funded by the Bill & Melinda Gates Foundation. The funding will be used to assess the added value Nanoform’s CESS nanoparticle engineering technology can deliver to several of its drug development projects. “Our goal is to improve the lives of over 1 billion patients. We […]
Biotech Business - September 29, 2021
SmartCella raises 328 million SEK
SmartCella Holding has announced the raising to further advance and accelerate the development of core technologies in the company’s three business units, Procella Therapeutics, Smartwise and SvedMed Solutions. The financing, led by advisor SEB, brings together a renowned group of investors with AMF, SEB Pension, Alto Cumulus and Celox joining existing investors including AP4 and […]
Biotech Business - September 20, 2021
Intrance Medical Systems raises 8 million USD
Intrance Medical Systems Inc, a subsidiary of Sweden-based Intrance Holdings AB, has secured financing from Swedish real estate investor Erik Selin through his private company, Erik Selin Fastigheter AB. Erik Selin has agreed to become the anchor investor as part of a Series A financing round of 15 million USD, becoming the largest shareholder next […]
Financing - September 17, 2021
NordicRWE granted 16 million NOK
The Research Council of Norway recently awarded a grant to the new company NordicRWE. NordicRWE was granted 16 million NOK for their research and development (R&D) project that will focus on applying Real-World Evidence (RWE) in different steps in the drug development process, reports Oslo Cancer Cluster. The vision of NordicRWE The vision of NordicRWE […]
Financing - September 15, 2021
Follicum pauses all of its development projects
Following results from a phase 2 study of FOL-005, for the treatment of hair loss, the Board of the company decided to evaluate the company’s business strategy and long-term goals. The board of Follicum has now estimated that the company, in its current situation, will have difficulties in attracting financing for further operations of the […]
Biotech Business - September 9, 2021
Diamyd Medical raises 150 million SEK
Diamyd Medical has successfully completed a directed share issue of 5 357 143 B-shares at a price of SEK 28 per share. Through the Directed Share Issue, the company will receive gross proceeds of SEK 150 million. The Directed Share Issue was subscribed by qualified investors, states the company. ”The company is developing strongly and […]
